Neuropeptide Y Receptor Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064632
  • May 2021
  • Biotechnology
  • 121 Pages
The Neuropeptide Y Receptor market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Neuropeptide Y Receptor market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Gila Therapeutics Inc, Novo Nordisk A/S., XL-protein GmbH, Novartis AG, Pfizer Inc., Merck & Co., Inc, Mannkind Corp., Gilead Sciences Inc, Genentech, Inc., Lilly Eli
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Neuropeptide Y Receptor market along with their effects over the forecast period. Similarly, according to the region Neuropeptide Y Receptor market research report includes the study of opportunities available in the market situation.

The Neuropeptide Y Receptor market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Neuropeptide Y Receptor Market:
The Neuropeptide Y Receptor market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Gila Therapeutics Inc, Novo Nordisk A/S., XL-protein GmbH, Novartis AG, Pfizer Inc., Merck & Co., Inc, Mannkind Corp., Gilead Sciences Inc, Genentech, Inc., Lilly Eli

Neuropeptide Y Receptor Market Segmentation Analysis:
By Product
Food Grade
Pharmaceutical Grade
End Use
Medicine
Food Additives
Others
Stimulation
Vagus Nerve Stimulation
End Use
Pain Management
Parkinson\'s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Others


Global Neuropeptide Y Receptor Market Segmentation by Regions:
In regional analysis, Neuropeptide Y Receptor market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Neuropeptide Y Receptor market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Neuropeptide Y Receptor Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Neuropeptide Y Receptor Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Neuropeptide Y Receptor Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Neuropeptide Y Receptor Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Neuropeptide Y Receptor Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Neuropeptide Y Receptor market, according to the key region.
  • To study the Neuropeptide Y Receptor market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Neuropeptide Y Receptor market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Neuropeptide Y Receptor research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Neuropeptide Y Receptor market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Neuropeptide Y Receptor market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Neuropeptide Y Receptor market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Neuropeptide Y Receptor market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Neuropeptide Y Receptor market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Gila Therapeutics Inc
  • Novo Nordisk A/S.
  • XL-protein GmbH
  • Novartis AG
  • Pfizer Inc.
  • Merck & Co., Inc
  • Mannkind Corp.
  • Gilead Sciences Inc
  • Genentech, Inc.
  • Lilly Eli
  • Food Grade
  • Pharmaceutical Grade
  • Pain Management
  • Parkinson's Disease
  • Urinary and Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Neuropeptide Y Receptor Market Snapshot
          2.1.1. Global Neuropeptide Y Receptor Market By Product,2019
               2.1.1.1.Food Grade
               2.1.1.2.Pharmaceutical Grade
          2.1.2. Global Neuropeptide Y Receptor Market By End Use,2019
               2.1.2.1.Pain Management
               2.1.2.2.Parkinson's Disease
               2.1.2.3.Urinary and Fecal Incontinence
               2.1.2.4.Epilepsy
               2.1.2.5.Gastroparesis
               2.1.2.6.Others
          2.1.3. Global Neuropeptide Y Receptor Market By End-use,2019
          2.1.4. Global Neuropeptide Y Receptor Market By Geography,2019

3. Global Neuropeptide Y Receptor Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Neuropeptide Y Receptor Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Neuropeptide Y Receptor Market Size (US$), By Product, 2018 – 2028

5. Global Neuropeptide Y Receptor Market Size (US$), By End Use, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End Use, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End Use, 2020
     5.2. Global Neuropeptide Y Receptor Market Size (US$), By End Use, 2018 – 2028

6. Global Neuropeptide Y Receptor Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Neuropeptide Y Receptor Market Size (US$), By End-use, 2018 – 2028

7. Global Neuropeptide Y Receptor Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Neuropeptide Y Receptor Market Analysis, 2018 – 2028 
          7.2.1. North America Neuropeptide Y Receptor Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Neuropeptide Y Receptor Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Neuropeptide Y Receptor Market Size (US$), By End Use, 2018 – 2028
          7.2.4. North America Neuropeptide Y Receptor Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Neuropeptide Y Receptor Market Analysis, 2018 – 2028 
          7.3.1.  Europe Neuropeptide Y Receptor Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Neuropeptide Y Receptor Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Neuropeptide Y Receptor Market Size (US$), By End Use, 2018 – 2028
          7.3.4. Europe Neuropeptide Y Receptor Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Neuropeptide Y Receptor Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Neuropeptide Y Receptor Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Neuropeptide Y Receptor Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Neuropeptide Y Receptor Market Size (US$), By End Use, 2018 – 2028
          7.4.4. Asia Pacific Neuropeptide Y Receptor Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Neuropeptide Y Receptor Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Neuropeptide Y Receptor Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Neuropeptide Y Receptor Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Neuropeptide Y Receptor Market Size (US$), By End Use, 2018 – 2028
          7.5.4. Latin America Neuropeptide Y Receptor Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Neuropeptide Y Receptor Market Analysis, 2018 – 2028 
          7.6.1.  MEA Neuropeptide Y Receptor Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Neuropeptide Y Receptor Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Neuropeptide Y Receptor Market Size (US$), By End Use, 2018 – 2028
          7.6.4. MEA Neuropeptide Y Receptor Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Neuropeptide Y Receptor Providers
        8.4.1 Gila Therapeutics Inc
                8.4.1.1 Business Description
                8.4.1.2 Gila Therapeutics Inc Geographic Operations
                8.4.1.3 Gila Therapeutics Inc Financial Information
                8.4.1.4 Gila Therapeutics Inc Product Positions/Portfolio
                8.4.1.5 Gila Therapeutics Inc Key Developments
        8.4.2 Novo Nordisk A/S.
                8.4.2.1 Business Description
                8.4.2.2 Novo Nordisk A/S. Geographic Operations
                8.4.2.3 Novo Nordisk A/S. Financial Information
                8.4.2.4 Novo Nordisk A/S. Product Positions/Portfolio
                8.4.2.5 Novo Nordisk A/S. Key Developments
        8.4.3 XL-protein GmbH
                8.4.3.1 Business Description
                8.4.3.2 XL-protein GmbH Geographic Operations
                8.4.3.3 XL-protein GmbH Financial Information
                8.4.3.4 XL-protein GmbH Product Positions/Portfolio
                8.4.3.5 XL-protein GmbH Key Developments
        8.4.4 Novartis AG
                8.4.4.1 Business Description
                8.4.4.2 Novartis AG Geographic Operations
                8.4.4.3 Novartis AG Financial Information
                8.4.4.4 Novartis AG Product Positions/Portfolio
                8.4.4.5 Novartis AG Key Developments
        8.4.5 Pfizer Inc.
                8.4.5.1 Business Description
                8.4.5.2 Pfizer Inc. Geographic Operations
                8.4.5.3 Pfizer Inc. Financial Information
                8.4.5.4 Pfizer Inc. Product Positions/Portfolio
                8.4.5.5 Pfizer Inc. Key Developments
        8.4.6 Merck & Co., Inc
                8.4.6.1 Business Description
                8.4.6.2 Merck & Co., Inc Geographic Operations
                8.4.6.3 Merck & Co., Inc Financial Information
                8.4.6.4 Merck & Co., Inc Product Positions/Portfolio
                8.4.6.5 Merck & Co., Inc Key Developments
        8.4.7 Mannkind Corp.
                8.4.7.1 Business Description
                8.4.7.2 Mannkind Corp. Geographic Operations
                8.4.7.3 Mannkind Corp. Financial Information
                8.4.7.4 Mannkind Corp. Product Positions/Portfolio
                8.4.7.5 Mannkind Corp. Key Developments
        8.4.8 Gilead Sciences Inc
                8.4.8.1 Business Description
                8.4.8.2 Gilead Sciences Inc Geographic Operations
                8.4.8.3 Gilead Sciences Inc Financial Information
                8.4.8.4 Gilead Sciences Inc Product Positions/Portfolio
                8.4.8.5 Gilead Sciences Inc Key Developments
        8.4.9 Genentech, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Genentech, Inc. Geographic Operations
                8.4.9.3 Genentech, Inc. Financial Information
                8.4.9.4 Genentech, Inc. Product Positions/Portfolio
                8.4.9.5 Genentech, Inc. Key Developments
        8.4.10 Lilly Eli
                8.4.10.1 Business Description
                8.4.10.2 Lilly Eli Geographic Operations
                8.4.10.3 Lilly Eli Financial Information
                8.4.10.4 Lilly Eli Product Positions/Portfolio
                8.4.10.5 Lilly Eli Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Neuropeptide Y Receptor Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Neuropeptide Y Receptor Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Neuropeptide Y Receptor Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Neuropeptide Y Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Neuropeptide Y Receptor Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Neuropeptide Y Receptor Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Neuropeptide Y Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Neuropeptide Y Receptor Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Neuropeptide Y Receptor Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Neuropeptide Y Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Neuropeptide Y Receptor Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Neuropeptide Y Receptor Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Neuropeptide Y Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Neuropeptide Y Receptor Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Neuropeptide Y Receptor Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Neuropeptide Y Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Neuropeptide Y Receptor: Market Segmentation 
FIG. 2 Global Neuropeptide Y Receptor Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Neuropeptide Y Receptor Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Neuropeptide Y Receptor Market, By End Use, 2019 (US$ Mn) 
FIG. 6 Global Neuropeptide Y Receptor Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Neuropeptide Y Receptor Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Neuropeptide Y Receptor Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Neuropeptide Y Receptor Providers, 2019
FIG. 11 Global Neuropeptide Y Receptor Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Neuropeptide Y Receptor Market Revenue Contribution, By End Use, 2019 & 2028 (Value %) 
FIG. 13 Global Neuropeptide Y Receptor Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Neuropeptide Y Receptor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Neuropeptide Y Receptor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Neuropeptide Y Receptor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Neuropeptide Y Receptor Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Neuropeptide Y Receptor Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Neuropeptide Y Receptor market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Neuropeptide Y Receptor Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Neuropeptide Y Receptor Market Value, By Segment1, 2018 – 2028
TABLE  North America Neuropeptide Y Receptor Market Value, By Segment2, 2018 – 2028
TABLE  North America Neuropeptide Y Receptor Market Value, By Country, 2018 – 2028
TABLE  Europe Neuropeptide Y Receptor Market Value, By Segment1, 2018 – 2028
TABLE  Europe Neuropeptide Y Receptor Market Value, By Segment2, 2018 – 2028
TABLE  Europe Neuropeptide Y Receptor Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Neuropeptide Y Receptor Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Neuropeptide Y Receptor Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Neuropeptide Y Receptor Market Value, By Country, 2018 – 2028
TABLE  Latin America Neuropeptide Y Receptor Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Neuropeptide Y Receptor Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Neuropeptide Y Receptor Market Value, By Country, 2018 – 2028
TABLE  MEA Neuropeptide Y Receptor Market Value, By Segment1, 2018 – 2028
TABLE  MEA Neuropeptide Y Receptor Market Value, By Segment2, 2018 – 2028
TABLE  MEA Neuropeptide Y Receptor Market Value, By Country, 2018 – 2028
TABLE  Gila Therapeutics Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novo Nordisk A/S.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  XL-protein GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mannkind Corp.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead Sciences Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Genentech, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lilly Eli: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Neuropeptide Y Receptor Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Neuropeptide Y Receptor Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Neuropeptide Y Receptor Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Neuropeptide Y Receptor Market, By Geography, 2019 (US$ Mn)
FIG.  Global Neuropeptide Y Receptor Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Neuropeptide Y Receptor Providers, 2016
FIG.  Global Neuropeptide Y Receptor Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Pharmaceutical Grade Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Neuropeptide Y Receptor Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Parkinson's Disease Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Urinary and Fecal Incontinence Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Epilepsy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gastroparesis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Neuropeptide Y Receptor Market Value, 2018 – 2028, (US$ Mn)